Medinotec (MDNC) Operating Leases (2024 - 2025)
Medinotec posted quarterly Operating Leases of $5355.0 for Q2 2025, down 84.19% year-on-year from $33873.0 in Q2 2024, and down 57.82% on a QoQ basis from $12696.0 in Q1 2025.
Medinotec (MDNC) has 2 years of Operating Leases data on file, last reported at $5355.0 in Q2 2025.
- For the quarter ending Q2 2025, Operating Leases fell 84.19% year-over-year to $5355.0; the trailing twelve-month figure through May 2025 stood at $5355.0 (down 84.19% YoY), and the FY2025 full-year result was $12696.0, down 68.02% from the prior year.
- Operating Leases for Q2 2025 stood at $5355.0, down from $12696.0 in the prior quarter.
- Across five years, Operating Leases topped out at $39698.0 in Q1 2024 and bottomed at $5355.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Medinotec | - | - | 854,557.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 5,355.00 |
| Feb 28, 2025 | 12,696.00 |
| Nov 30, 2024 | 20,731.00 |
| Aug 31, 2024 | 28,454.00 |
| May 31, 2024 | 33,873.00 |
| Feb 29, 2024 | 39,698.00 |